Results 21 to 30 of about 26,607 (119)

Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies

BMC Musculoskeletal Disorders, 2009
Background Occurrence of atrial fibrillation (AF) amongst bisphosphonate users has been increasingly reported but results are conflicting. We performed a Bayesian meta-analysis to address the possible association between the occurrence of AF and ...
Cheak Alicia, Ho Roger, Cheung Mike WL, Mak Anselm, Lau Chak   +4 more
doaj   +1 more source

Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene diphosphonate

eLife, 2022
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) presents as a morbid jawbone lesion in patients exposed to a nitrogen-containing bisphosphonate (N-BP). Although it is rare, BRONJ has caused apprehension among patients and healthcare providers and
Hiroko Okawa, Takeru Kondo, Akishige Hokugo, Philip Cherian, Jesus J Campagna, Nicholas A Lentini, Eric C Sung, Samantha Chiang, Yi-Ling Lin, Frank H Ebetino, Varghese John, Shuting Sun, Charles E McKenna, Ichiro Nishimura   +13 more
doaj   +1 more source

Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a sistematic review

Reumatismo, 2011
Osteonecrosis of the jaw (ONJ) is a well-known devastating side effect of parenteral bisphosphonate therapy for cancer. Several ONJ cases have been reported in patients taking oral bisphosphonates for osteoporosis or Paget’s disease.
F. Capsoni
doaj   +1 more source

Etidronate as A Weak Chelating Agent on Root Canal Dentin: An Update Review [PDF]

Journal of Clinical and Diagnostic Research, 2017
Successful root canal treatment depends on proper biomechanical cleaning and shaping of root canal system followed by threedimensional obturation. Irrigation solutions and chelating agents are used during root canal treatment to assist in smear layer ...
Samah Samir Bedir, Hossam Mossa, Ahmed Mohammed Hassan   +2 more
doaj   +1 more source

Effects of teriparatide and bisphosphonate on spinal fusion procedure: A systematic review and network meta-analysis.

PLoS ONE, 2020
BackgroundGiving patients anti-osteoporotic agents peri-operatively is a well-accepted strategy to increase fusion rate and prevent complications. The purpose of this study was to investigate effectiveness of teriparatide and bisphosphonate on fusion ...
Shih-Hao Cheng, Yi-Jie Kuo, Chiehfeng Chen, Yi-No Kang   +3 more
doaj   +1 more source

Unexpected iatrogenic fracture of the femoral neck during subtrochanteric fracture fixation in a patient on bisphosphonate treatment for osteoporosis: Case report

Trauma Case Reports, 2020
Osteoporotic patients being treated with bisphosphonates present an interesting dilemma when removing hardware such as dynamic hip screws “DHS”. In this paper, we describe the case of a 66-year-old osteoporotic patient who was placed on long term ...
Bardia Barimani, Kashif Khan, Fahad Abduljabbar, Monica Volesky, John Antoniou   +4 more
doaj   +1 more source

Anti‐Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture

Orthopaedic Surgery, 2019
Objective To study the effect of anti‐osteoporosis therapies on mortality after hip fracture. Methods This retrospective study was carried out in the Second Affiliated Hospital of Fujian Medical University and enrolled 690 patients 50 years of age and ...
Pei‐wen Wang, Yi‐zhong Li, Hua‐feng Zhuang, Hai‐ming Yu, Si‐qing Cai, Hao Xu, Zhen‐hui Chen, Jin‐kuang Lin, Xue‐dong Yao   +8 more
doaj   +1 more source

Proximal femoral reconstruction for failed internal fixation of a bisphosphonate-related femur fracture

Arthroplasty Today, 2016
We present a case of a bisphosphonate-related femur fracture in an elderly woman, who failed treatment with both cephalomedullary nail and proximal femoral locking plate, leading to successful treatment with total hip arthroplasty.
Rishabh G. Jethanandani, BSE, Chima Nwankwo, MD, Philip R. Wolinsky, MD, Mauro Giordani, MD, Derek F. Amanatullah, MD, PhD   +4 more
doaj   +1 more source

A brief review and clinical evidences of teriparatide therapy for atypical femoral fractures associated with long-term bisphosphonate treatment

Frontiers in Surgery, 2023
The risk of bisphosphonate (BP)-associated atypical femur fracture (AFF) has markedly increased over recent decades due to suppression of bone turnover, accumulation of structural micro-damage and reduction of bone remodeling consequent to long-term BP ...
Jianpeng Gao, Jianpeng Gao, Xiao Liu, Xiao Liu, Xiaoyong Wu, Xiaoya Li, Jianheng Liu, Jianheng Liu, Ming Li, Ming Li   +9 more
doaj   +1 more source

Clinical features of atypical femur fracture

Osteoporosis and Sarcopenia, 2016
Objectives: We aim to elucidate the clinical outcomes of bisphosphonate-associated atypical femoral fracture and the clinical results depending on the bisphosphonate therapy period.
Joong Sup Shin, Nak Chul Kim, Kyoung Ho Moon   +2 more
doaj   +1 more source